VULTAGGIO, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.365
EU - Europa 6.367
AS - Asia 4.686
SA - Sud America 588
AF - Africa 113
OC - Oceania 69
Continente sconosciuto - Info sul continente non disponibili 1
Totale 20.189
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.246
RU - Federazione Russa 1.995
IT - Italia 1.422
SG - Singapore 1.396
CN - Cina 1.174
PL - Polonia 1.136
HK - Hong Kong 618
VN - Vietnam 458
BR - Brasile 456
SE - Svezia 407
IE - Irlanda 374
KR - Corea 351
DE - Germania 230
FI - Finlandia 203
FR - Francia 185
GB - Regno Unito 143
IN - India 143
BD - Bangladesh 140
JO - Giordania 93
UA - Ucraina 79
JP - Giappone 76
AU - Australia 66
CA - Canada 56
TR - Turchia 56
AR - Argentina 55
ID - Indonesia 51
NL - Olanda 48
CH - Svizzera 34
MX - Messico 32
ES - Italia 30
NG - Nigeria 24
BE - Belgio 21
CI - Costa d'Avorio 21
IQ - Iraq 21
EC - Ecuador 20
ZA - Sudafrica 17
VE - Venezuela 15
PK - Pakistan 13
AE - Emirati Arabi Uniti 11
CO - Colombia 11
IL - Israele 11
MA - Marocco 11
UY - Uruguay 11
AT - Austria 10
LT - Lituania 10
PH - Filippine 10
CZ - Repubblica Ceca 9
TH - Thailandia 9
CL - Cile 8
EG - Egitto 8
TN - Tunisia 8
UZ - Uzbekistan 8
JM - Giamaica 7
SA - Arabia Saudita 7
PY - Paraguay 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
NP - Nepal 5
BJ - Benin 4
GT - Guatemala 4
OM - Oman 4
PA - Panama 4
PE - Perù 4
BY - Bielorussia 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
KE - Kenya 3
LV - Lettonia 3
MY - Malesia 3
NI - Nicaragua 3
RO - Romania 3
SC - Seychelles 3
SN - Senegal 3
TW - Taiwan 3
AL - Albania 2
BB - Barbados 2
BO - Bolivia 2
HN - Honduras 2
HR - Croazia 2
IR - Iran 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
NC - Nuova Caledonia 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
Totale 20.175
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.528
Ashburn 1.207
Warsaw 1.132
Singapore 981
Fairfield 584
Hong Kong 517
Chandler 445
Dublin 373
San Jose 373
Seoul 350
Milan 267
Hefei 263
Cambridge 241
Beijing 234
Seattle 232
Houston 225
Woodbridge 223
Wilmington 216
Florence 158
Ann Arbor 144
Los Angeles 143
Buffalo 140
Ho Chi Minh City 139
New York 121
Jacksonville 119
Lawrence 118
Altamura 116
The Dalles 115
Munich 111
Hanoi 110
Lauterbourg 107
Rome 104
Dallas 99
Princeton 96
Elk Grove Village 91
Moscow 89
Council Bluffs 87
Boardman 70
Boston 68
Helsinki 68
Mumbai 64
Shanghai 64
Melbourne 59
Kent 53
Tokyo 52
Paris 51
Medford 45
Turku 43
San Diego 40
São Paulo 40
Jakarta 37
Naples 37
Izmir 35
Frankfurt am Main 26
Lappeenranta 25
Dong Ket 24
London 24
Chicago 23
Luni 22
Abidjan 21
Brooklyn 21
Palermo 21
Abuja 20
Norwalk 20
Bologna 19
Figino 19
Orem 19
Toronto 19
Bern 17
Brussels 17
Chennai 17
Falls Church 17
Phoenix 17
Bari 16
Clifton 16
Genoa 16
Guangzhou 16
Madrid 16
Redondo Beach 16
Tianjin 15
Washington 14
Montreal 13
Salerno 13
Turin 13
Xi'an 13
Yubileyny 13
Zurich 13
Biên Hòa 12
Haiphong 12
Johannesburg 12
Brasília 11
Da Nang 11
Denver 11
Hải Dương 11
Padua 11
Philadelphia 11
Andover 10
Baghdad 10
Dhaka 10
Manchester 10
Totale 13.177
Salva come PNG Salva come JPEG
Nome #
A novel allergen-adjuvant conjugate suitable for specific immunotherapy of respiratory allergy 382
Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammation 362
Hapten-Specific TH17 Cells in the Peripheral Blood of β-Lactam-Induced AGEP. 323
Dermatophagoides pteronyssinus group 2 allergen bound to 8-OH modified adenine reduces the Th2-mediated airway inflammation without inducing a Th17 response and autoimmunity 299
Mepolizumab Reduces Inflammatory Eosinophils in Nasal Polyp Tissue and Restores Histological Alterations 296
The in vitro amplification of β-lactam-specific memory t cells improves the diagnostic performance of IGE detection and lymphocyte transformation test 286
Potential underestimation of risks in hazelnuts-allergic patients: a peculiar case report 267
Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study 261
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies 257
T cells specific for Candida albicans antigens and producing type 2 cytokines in lesional mucosa of untreated HIV-infected patients with pseudomembranous oropharyngeal candidiasis. 241
Efficacy and safety of mepolizumab (Anti-Interleukin-5) treatment in Gleich's syndrome 234
Biweekly hizentra® in primary immunodeficiency: A multicenter, observational cohort study (IBIS) 225
High proportion of inflammatory CD62Llow eosinophils in blood and nasal polyps of severe asthma patients 223
Th2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens. 213
High serum β-lactams specific/total IgE ratio is associated with immediate reactions to β-lactams antibiotics 213
Miescher's cheilitis: Surgical management and long term outcome of an extremely severe case. 209
Assessment of the risk of polyomavirus JC reactivation in patients with immune-mediated diseases during long-term treatment with infliximab 208
The TLR7 Ligand 9-Benzyl-2-Butoxy-8-Hydroxy Adenine Inhibits IL-17 Response by Eliciting IL-10 and IL-10-Inducing Cytokines. 206
Blood CD62Llow inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumab 205
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020 204
Skin testing and infliximab-specific antibodies detection as a combined strategy for preventing infusion reaction. 204
The percentage of patients achieving complete remission of urticaria increases with repeated courses of treatment 201
Microchimerism and systemic sclerosis 200
A novel allergen-adjuvant conjugate suitable for allergen-specific Th2 redirection 199
Assays and strategies for immunogenicity assessment of biological agents. 199
Detection by flow cytometry of ESAT-6- and PPD-specific circulating CD4+ T lymphocytes as a diagnostic tool for tuberculosis. 195
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 192
Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency in Routine Clinical Practice: The VISPO Prospective Multicenter Study 190
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 189
Corrigendum to "Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia" [Int. Immunopharmacol. 44 (2017) 38-42] 188
Drug-Specific Th2 Cells and IgE Antibodies in a Patient with Anaphylaxis to Rituximab 186
A novel nDer p2-conjugated TLR7 down-modulates Th2-associated lung inflammation by using a therapeutical protocol 185
Correlations Among Subcutaneous Immunoglobulin Dosage, Immunoglobulin G Serum Pre-infusional Levels and Body Mass Index in Primary Antibody Deficiency Patients: A Pooled Analysis from the SHIFT/IBIS Studies 184
Vav1 haploinsufficiency in a common variable immunodeficiency patient with defective T-cell function. 183
Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions. 181
Omalizumab dampens type 2 inflammation in a group of long-term treated asthma patients and detaches IgE from FcεRI 180
Subcutaneous Immunoglobulin Twenty Percent Every Two Weeks in Pediatric Patients with Primary Immunodeficiencies: Subcohort Analysis of the IBIS Study 177
The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer 175
Can SSRI/SNRI antidepressants decrease the 'cytokine storm' in the course of COVID-19 pneumonia? 174
Urinary rituximab loss and rate of treatment failure in membranous nephropathy 173
Redirection of allergen-specific Th2 responses by a modified adenine through Toll-like receptor 7 interaction and IL-12/IFN release 173
Seasonal Allergic Rhinitis Symptoms in Relation to COVID-19 172
Manifestations of Antidrug Antibodies Response: Hypersensitivity and Infusion Reactions. 169
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study 167
Defective production of LIF, M-CSF and Th2-type cytokines by T cells at fetomaternal interface is associated with pregnancy loss. 166
Low-dose mepolizumab effectiveness in patients suffering from eosinophilic granulomatosis with polyangiitis 165
A modified adenine chemically coupled to allergenic molecule(s) as inducer of allergen-specific Th2 cells redirection 165
A modified adenines chemically coupled to allergen molecule of dermatophagoides pteronyssinus down-regulates allergen-specific Th2 cells responses 164
EGPA Phenotyping: Not Only ANCA, but Also Eosinophils 163
A modified adenine chemically coupled to the allergen molecule of Dermatophagoides pteronyssinus redirects allergen-specific Th2 cells 162
PS1-076. Redirection of allergen-specific TH2 cells by a modified adenine chemically coupled to allergenic molecule(s) 162
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 160
"Sarcoidosis-like" granulomatous disease in patients with common variable hypogammaglobulinemia 159
Apten-specific proliferation as diagnostic tool in drug hypersensitivity. 158
A modified adenine chemically coupled to allergen molecole redirects allergen-specific Th2 cells 158
Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia. 157
Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience 156
A novel antigen-conjugated TLR7 ligand regulates the lung inflammation and Th2-mediated response in a murine model of asthma 156
A modified adenine chemically coupled to allergen molecule(s) induce Interferon-gamma production and down regulate IL-4 and IL-5 in Th2 specific T cells 156
Modified adenine (9-benzyl-2-butoxy-8-hydroxyadenine) redirects Th2-mediated murine lung inflammation by triggering TLR7. 156
Primary antibody deficiencies represent an underestimated comorbidity in asthma patients: efficacy of immunoglobulin replacement therapy in asthma control 153
Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study 153
Anti-RuvBL1/2 Autoantibodies Detection in a Patient with Overlap Systemic Sclerosis and Polymyositis 152
Association between "sarcoidosis-like" disease and common variable immunodeficiency (CVI): a new CVI variant showing an activation of the immune system. 151
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity 151
Effectiveness of tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real-life study 149
Safety and tolerability of infliximab therapy: suggestions and criticisms based on wide clinical experience. 149
Baseline Eosinophil Count as a Potential Clinical Biomarker for Clinical Complexity in EGPA: A Real-Life Experience 148
Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies 147
A modified adenines chemically coupled to allergenic molecule(s) as inducerof allergen-specific Th2 cells redirection 145
Effectiveness of low-dose intravenous immunoglobulin therapy in minor primary antibody deficiencies: a two-year real-life experience 144
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 143
Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis 141
Modified adenine (9-benzyl-2-butoxy-8-hydroxyadenine) redirects Th2-mediated murine lung inflammation by triggering TLR7. 141
T cells specific for Candida albicans antigens and producing type 2 cytokines in lesional mucosa of untreated HIV-infected patients with pseudomembranous oropharyngeal candidiasis 140
Total serum IgE levels influence the in vitro detection of ss-lactams-specific IgE antibodies 139
Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab. 139
Hydroxy-adenines as in vivo and in vitro immunomodulators of allergic responses 138
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent 136
Modified adenines chemically coupled to allergen molecule induce interferon-gamma production and down-regulate IL-4 and IL-5 in Th2-specific T cells 134
Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions 133
Adalimumab and anti-adalimumab antibodies a novel method of detection and quantification in human sera based on surface plasmon resonance technique 132
Coronary vasospasm during an acute allergic reaction 132
Poly(I:C) promotes the production of IL-17A by murine CD1d-driven invariant NKT cells in airway inflammation. 132
Alert Card for Patients on Biologicals and Immunosuppressives: An EAACI Position Paper 131
The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated Disorders 129
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent 128
Case Report: A child with NFKB1 haploinsufficiency explaining the linkage between immunodeficiency and short stature 126
Short and long-term effect of a novel nDer p2-conjugated TLR7 ligand in the prevention of allergic lung inflammation 126
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC) 125
Multiorgan Infiltration by CD8+ T Cells and 1p;16p Translocation in a Patient with Hypogammaglobulinemia and a Reduced Number of B Cells. 125
Type 1 T helper cells specific for Candida albicans antigens in peripheral blood and vaginal mucosa of women with recurrent vaginal candidiasis. 124
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life 122
Lack of efficacy of Cyclosporine A in a patient with episodic angioedema and eosinophilia (Gleich's syndrome) 122
Sustained Effectiveness of Benralizumab in Naïve and Biologics-Experienced Severe Eosinophilic Asthma Patients: Results from the ANANKE Study 121
Influence of total serum IgE levels on the in vitro detection of beta-lactams-specific IgE antibodies. 121
T-cell responses during allergen-specific immunotherapy. 119
Highly active antiretroviral therapy including inhibitory proteases in HIV-infected patients induces a restored T cell-mediated immune response to C. albicans antigens and Th1 profile [abstract]. 118
Immediate adverse reactions to biologicals:from pathogenic mechanisms to prophylactic management 118
Effects of Mepolizumab in the treatment of type 2 CRSwNP: a real-life clinical study 117
Totale 17.507
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.829
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.829
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202165 0 0 0 0 0 0 0 0 0 0 0 65
2021/2022657 20 60 45 19 23 36 33 59 25 32 134 171
2022/20231.843 150 367 92 148 133 313 231 98 218 14 45 34
2023/2024873 36 71 106 60 80 110 59 166 17 54 71 43
2024/20255.295 187 546 310 856 1.390 557 102 357 266 144 257 323
2025/20267.879 874 968 689 641 856 274 868 336 525 522 375 951
Totale 20.324